Neurophth Competitors and Similar CompaniesClear all
Neurophth's competitors and similar companies include BioCryst Pharmaceuticals, Proteros, Fortress Biotech and Aptuit.
 Neurophth Neurophth is a fully integrated genomic medicines company dedicated to seeking to improve lives through the curative potential of gene therapies. |  BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. |  Fortress Biotech Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. |  Aptuit Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions. | ||
Founding Date | Founding Date 2016 | Founding Date 1986 | Founding Date 2000 | Founding Date 2006 | Founding Date 1993 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations HQ | Locations Durham, US HQ Hoover, US | Locations Planegg, DE HQ Cambridge, US | Locations New York, US HQ Waltham, US | Locations Greenwich, US HQ Verona, IT Reinach, CH Milton, GB |
Employees | Employees 422% increase | Employees 14040% increase | Employees 147 | Employees 10146% decrease | Employees 761 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.7 b | Valuation ($) N/A | Valuation ($) 55.7 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $874.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $63.3m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $19.1m (FY, 2025) | Cost of goods N/A | Cost of goods $20.9m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $855.8m (FY, 2025) | Gross profit N/A | Gross profit $42.3m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income $263.9m (FY, 2025) | Net income N/A | Net income ($32.9m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 60m | Total funding raised $ 1.9m | Total funding raised $ 7m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
BioCryst Pharmaceuticals
HQ
Durham, US
Employees
140↑ 40% increase
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
View company
Proteros
HQ
Planegg, DE
Proteros biostructures is a company that provides early-stage drug discovery services.
View companyFortress Biotech
HQ
New York, US
Employees
101↓ 46% decrease
Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.
View companyAptuit
HQ
Greenwich, US
Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions.
View company